Detection of malignant cells in the peripheral blood of patients with multiple myeloma

Clinical implications and research applications

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: To review the methods for detecting and quantifying malignant cells in the peripheral blood (PB) and to correlate such cells with the activity of multiple myeloma (MM). Design: Results of personal investigations and studies reported in the literature were summarized. Results: MM is characterized by a monoclonal proliferation of plasma cells in the bone marrow. Although usually clinically inapparent, these plasma cells can circulate in the PB and be detected by use of sensitive immunofluorescence, flow cytometric, or molecular genetic techniques. The detection of these cells is clinically important because they correlate with disease activity. As MM progresses, the plasma cells appear in greater numbers in the PB. When patients respond to chemotherapy, the number of circulating plasma cells decreases. Conclusion: Determining the molecular, immunologic, and morphologic characteristics of the circulating cells is important for improving our understanding of the pathogenesis of MM and deciding which cells to target therapeutically.

Original languageEnglish (US)
Pages (from-to)903-907
Number of pages5
JournalMayo Clinic Proceedings
Volume69
Issue number9
StatePublished - 1994

Fingerprint

Multiple Myeloma
Plasma Cells
Research
Genetic Techniques
Fluorescent Antibody Technique
Molecular Biology
Bone Marrow
Drug Therapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{96b6a4f9bc7444cd96fbac5194327de3,
title = "Detection of malignant cells in the peripheral blood of patients with multiple myeloma: Clinical implications and research applications",
abstract = "Objective: To review the methods for detecting and quantifying malignant cells in the peripheral blood (PB) and to correlate such cells with the activity of multiple myeloma (MM). Design: Results of personal investigations and studies reported in the literature were summarized. Results: MM is characterized by a monoclonal proliferation of plasma cells in the bone marrow. Although usually clinically inapparent, these plasma cells can circulate in the PB and be detected by use of sensitive immunofluorescence, flow cytometric, or molecular genetic techniques. The detection of these cells is clinically important because they correlate with disease activity. As MM progresses, the plasma cells appear in greater numbers in the PB. When patients respond to chemotherapy, the number of circulating plasma cells decreases. Conclusion: Determining the molecular, immunologic, and morphologic characteristics of the circulating cells is important for improving our understanding of the pathogenesis of MM and deciding which cells to target therapeutically.",
author = "Witzig, {Thomas Elmer}",
year = "1994",
language = "English (US)",
volume = "69",
pages = "903--907",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "9",

}

TY - JOUR

T1 - Detection of malignant cells in the peripheral blood of patients with multiple myeloma

T2 - Clinical implications and research applications

AU - Witzig, Thomas Elmer

PY - 1994

Y1 - 1994

N2 - Objective: To review the methods for detecting and quantifying malignant cells in the peripheral blood (PB) and to correlate such cells with the activity of multiple myeloma (MM). Design: Results of personal investigations and studies reported in the literature were summarized. Results: MM is characterized by a monoclonal proliferation of plasma cells in the bone marrow. Although usually clinically inapparent, these plasma cells can circulate in the PB and be detected by use of sensitive immunofluorescence, flow cytometric, or molecular genetic techniques. The detection of these cells is clinically important because they correlate with disease activity. As MM progresses, the plasma cells appear in greater numbers in the PB. When patients respond to chemotherapy, the number of circulating plasma cells decreases. Conclusion: Determining the molecular, immunologic, and morphologic characteristics of the circulating cells is important for improving our understanding of the pathogenesis of MM and deciding which cells to target therapeutically.

AB - Objective: To review the methods for detecting and quantifying malignant cells in the peripheral blood (PB) and to correlate such cells with the activity of multiple myeloma (MM). Design: Results of personal investigations and studies reported in the literature were summarized. Results: MM is characterized by a monoclonal proliferation of plasma cells in the bone marrow. Although usually clinically inapparent, these plasma cells can circulate in the PB and be detected by use of sensitive immunofluorescence, flow cytometric, or molecular genetic techniques. The detection of these cells is clinically important because they correlate with disease activity. As MM progresses, the plasma cells appear in greater numbers in the PB. When patients respond to chemotherapy, the number of circulating plasma cells decreases. Conclusion: Determining the molecular, immunologic, and morphologic characteristics of the circulating cells is important for improving our understanding of the pathogenesis of MM and deciding which cells to target therapeutically.

UR - http://www.scopus.com/inward/record.url?scp=0027935259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027935259&partnerID=8YFLogxK

M3 - Article

VL - 69

SP - 903

EP - 907

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 9

ER -